As a leading compounding pharmacy dedicated to advancing clinical knowledge, Ipharma Pharmacy offers this clinical white paper to provide practitioners with a nuanced, evidence-based perspective
This peptide discovered in 1973 by Pickart, has the highest concentration in young adults (age 25 and younger), when tissues have the most regenerative potential
Cell quality affects clinical outcome after MACI procedure for cartilage injury of the knee
This conclusion was also reached in another study (5)
How Its Being Used Youll find GHK-Cu in: Topical serums (often post-laser or with microneedling) Compounded injectables and transdermal creams (off-label) PRP and hair regrowth protocols Common use cases: Post-surgical healing Cosmetic skin rejuvenation Hair regrowth (stacked with PRP or exosomes) Scar treatment Wound support The Evidence: Topical use has shown skin improvements in small cosmetic trials Gene expression and lab studies support repair, inflammation reduction, and mitochondrial protection relevant to cognitive decline Systemic use (injections, high-dose protocols) lacks long-term safety and outcome data Results are highly individual and confounded by other interventions (PRP, microneedling, exosomes, etc.) Is It Safe